Radicava Ors

— THERAPEUTIC CATEGORIES —
  • Miscellaneous neurodegenerative disorders

Radicava Ors Generic Name & Formulations

General Description

Edaravone 105mg/5mL; oral susp; contains sodium bisulfite.

Pharmacological Class

Free radical scavenger.

See Also

How Supplied

Single-dose bags—1, 2; ORS Starter Kit (2×35mL)—1 (w. supplies); ORS Kit (1×50mL)—1 (w. supplies)

Generic Availability

NO

Radicava Ors Indications

Indications

Amyotrophic lateral sclerosis (ALS).

Radicava Ors Dosage and Administration

Adult

Use provided oral syringe. Give orally or via feeding tube on an empty stomach after overnight fasting. Avoid food for 1hr after administration, except water. Initial cycle: 105mg (5mL) daily in the morning for 14 days, followed by 14 days off. Subsequent cycles: 105mg daily for 10 days out of 14-day periods, followed by 14 days off. Switching from IV: use same dosing frequency.

Children

Not established.

Radicava Ors Contraindications

Not Applicable

Radicava Ors Boxed Warnings

Not Applicable

Radicava Ors Warnings/Precautions

Warnings/Precautions

Monitor for hypersensitivity reactions; discontinue and treat if occur. Asthma. Sulfite sensitivity. Pregnancy. Nursing mothers.

Radicava Ors Pharmacokinetics

See Literature

Radicava Ors Interactions

Not Applicable

Radicava Ors Adverse Reactions

Adverse Reactions

Contusion, gait disturbance, headache, dermatitis, eczema, respiratory failure/disorders, hypoxia, glycosuria, tinea infection; hypersensitivity reactions, anaphylaxis.

Radicava Ors Clinical Trials

See Literature

Radicava Ors Note

Not Applicable

Radicava Ors Patient Counseling

See Literature

Images